Track funded UK pharmaceutical companies, founders and investors across the UK startup ecosystem.
| Date | Startup | Funding | Round | Sector | Location | Connect | Website | Investor1 | Investor2 | Investor3 | Investor4 | Investor5 | Founder(s) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23 Jun 2026 | Astral Systems Astral Systems supplies modular Multi-State Fusion reactors designed as com... | £23,000,000 | |||||||||||
23 Jun 2026 | TRIMTECH Therapeutics TRIMTECH Therapeutics develops proprietary small-molecule degrader platform... | £11,000,000 | |||||||||||
22 Jun 2026 | Houdini Bio Houdini Bio offers a machine learning-guided DNA sequence design platform f... | £1,500,000 | |||||||||||
1 Jun 2026 | Inherent Faraday is a platform that pairs human researchers with AI agents to suppor... | £37,180,000 US$50,000,000 | |||||||||||
28 May 2026 | Perceptic Perceptic provides an AI operating system that integrates internal research... | £8,930,000 US$12,000,000 | |||||||||||
21 May 2026 | Imperagen Imperagen provides a closed-loop platform that uses AI and robotics to desi... | £5,000,000 | |||||||||||
14 May 2026 | Fractile Fractile makes inference chips and integrated systems for executing large l... | £160,000,000 | |||||||||||
12 May 2026 | Infex Therapeutics RESP-X is a monoclonal antibody that targets Pseudomonas aeruginosa in resp... | £4,300,000 | |||||||||||
12 May 2026 | Isomorphic Labs IsoDDE is an AI-driven engine that generates and evaluates molecules for dr... | £1,500,000,000 £1,500,000,000 | |||||||||||
11 May 2026 | Meatly Meatly develops and operates a pilot facility for producing cultivated meat... | £10,400,000 | |||||||||||
6 May 2026 | CellCentric Inobrodib is an oral p300/CBP epigenetic inhibitor. It is intended to treat... | £162,290,000 US$220,000,000 | |||||||||||
6 May 2026 | SugaROx SugaROx's product is a trehalose-6-phosphate biostimulant with a delivery t... | £2,500,000 | |||||||||||
5 May 2026 | EnteroBiotix EBX-102-02 is an orally delivered treatment that supplies a diverse microbi... | £19,000,000 | |||||||||||
5 May 2026 | Cytospire Therapeutics CYT X300 is a multispecific antibody that acts as a pan-gamma delta T cell ... | £61,000,000 | |||||||||||
22 Apr 2026 | QMatter QMatter provides a platform that uses quantum methods to shrink complex pro... | £900,000 | |||||||||||
15 Apr 2026 | Helical Helical provides a virtual lab and a model factory platform that integrates... | £7,370,000 US$10,000,000 | |||||||||||
15 Apr 2026 | Lightcast Envisia is a benchtop platform that captures direct functional measurements... | £19,910,000 US$27,000,000 | |||||||||||
7 Apr 2026 | WholeSum WholeSum is a software platform that converts unstructured text into struct... | £980,000 | |||||||||||
31 Mar 2026 | Semarion SemaCyte is a laboratory platform that places cells on barcoded microcarrie... | £2,880,000 US$3,800,000 | |||||||||||
19 Mar 2026 | Signals Signals provides research integrity software that analyses publication meta... | £827,000 US$1,100,000 | |||||||||||
17 Mar 2026 | Mestag Therapeutics MST-0312 is a FAP-targeted bispecific antibody that binds cells in tumours ... | £30,070,000 US$40,000,000 | |||||||||||
16 Mar 2026 | Ternary Therapeutics Ternary Therapeutics offers a discovery platform that uses machine learning... | £3,600,000 | |||||||||||
12 Mar 2026 | Combat Medical HIVEC is a medical device that delivers heated chemotherapy directly into t... | £2,600,000 | |||||||||||
3 Mar 2026 | Antiverse Antiverse's platform is a machine learning system that designs antibody can... | £7,000,000 | Cardiff | ||||||||||
2 Mar 2026 | Outpost Bio Outpost Bio provides a platform that combines automated laboratory experime... | £2,600,000 | |||||||||||
24 Feb 2026 | Centauri Therapeutics CTX-187 is a therapeutic candidate built on the Alphamer platform that targ... | £6,000,000 | |||||||||||
23 Feb 2026 | Eco-Inject Eco-Inject offers a redesigned, bio-based autoinjector compatible with exis... | £5,200,000 | |||||||||||
16 Feb 2026 | Tozaro Tozaro's Smart Polymer platform is a biomanufacturing technology using mole... | £6,000,000 | Bedford | ||||||||||
11 Feb 2026 | Sable Bio Sable Bio provides a software platform that uses machine learning and causa... | £2,700,000 | |||||||||||
11 Feb 2026 | AMPLY Discovery AMPLY Discovery is a biotech company that uses artificial intelligence and ... | Belfast |

1 Explore 102 UK pharmaceutical startups and their founders, who have collectively raised £3.96B.
2 Easily sort, filter, and compare the UK's top startups — customise the list to your needs.
3 Discover top startups for investment, B2B sales, partnerships, hiring, and industry connections.
You can connect with fast-growing pharmaceutical startups with the full list of recently funded startups from the UK.
With UK-based startups such as Ignota Labs, Medherant, and Stablepharma, the UK's pharmaceutical sector has rapidly become a hub for innovative drug development and delivery solutions. Driven by advancements in biotechnology, artificial intelligence, and a commitment to addressing unmet medical needs, pharmaceutical startups are transforming the landscape of healthcare by introducing novel therapies and improving patient outcomes.
Pharmaceutical startups are companies that focus on the research, development, and commercialisation of new drugs and therapies. They aim to address various medical conditions by discovering novel compounds, repurposing existing drugs, or enhancing drug delivery methods to improve efficacy and patient compliance.
These startups operate across diverse therapeutic areas, including oncology, neurology, and infectious diseases, often leveraging cutting-edge technologies such as artificial intelligence for drug discovery and development. By integrating scientific research with innovative approaches, they contribute to the advancement of medical science and the availability of new treatments.
With substantial funding and support from both the public and pharmaceutical investors, this ecosystem continues to expand rapidly. Let’s explore the key areas currently driving innovation within pharmaceutical startups:
Pharmaceutical startups in the UK are pioneering advancements across various domains by harnessing technological innovations and scientific research. Here are five distinct categories of pharmaceutical startups:
Companies utilising artificial intelligence to streamline the drug discovery process, reducing time and costs associated with bringing new medications to market (examples: Ignota Labs, BenevolentAI).
Startups developing advanced transdermal patches for drug delivery, offering controlled release and improved patient compliance (examples: Medherant).
Companies working on stabilising vaccines to eliminate the need for cold chain storage, enhancing accessibility in various regions (examples: Stablepharma).
Startups researching and developing psychedelic compounds for therapeutic use in mental health and neurological disorders (examples: Eleusis).
Companies creating digital tools to support pharmaceutical access, adherence, and patient engagement (examples: Healthera, Charac).